Omer Zaidi
2PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Mar 31, 2022
Real-world cost-effectiveness of primary prophylaxis with G-CSF biosimilars in patients at intermediate/high risk of febrile neutropenia.Paul Cornes, John Kelton, Rongzhe Liu
|Apr 27, 2021
Biosimilar pegfilgrastim may offer affordable treatment options for patients in France: a budget impact analysis on the basis of clinical trial and real-world data.Jingyan Yang, Rongzhe Liu, Anna Granghaud
Pageof 1
